News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analyst recommends buying Oracle common at $128 with a $115 stop and $160 target over about 45 trading days.
  • Oracle preferred shares, if available below $180, may offer superior risk/reward to common shares.
  • TOP Financial completed a cashless warrant exercise, issuing roughly 360.5 million restricted Class A shares and canceling remaining warrants.
  • TOP Financial's new shares are subject to a six-month lock-up.
  • Brookfield plans to combine its renewable and infrastructure dual-listed entities into single US-traded companies to boost liquidity and index inclusion, targeting Q4 2026.

Latest Articles

TOP Financial Group Limited Announces Full Exercise of All Outstanding Warrants Following Cashless Exercise

TOP Financial Group Limited Announces Full Exercise of All Outstanding Warrants Following Cashless Exercise

TOP Financial Group Limited announced the complete exercise of its outstanding warrants on a cashless basis, resulting in the issuance of approximately 360.5 million new Class A ordinary shares and cancellation of all remaining warrants. The newly issued shares are restricted and subject to a six-month lock-up period. The company operates diversifi…

TLX591-Tx ProstACT SELECT Study Published in Cancers Journal

TLX591-Tx ProstACT SELECT Study Published in Cancers Journal

Telix Pharmaceuticals announced the peer-reviewed publication of the ProstACT SELECT Phase 1 study results in the journal Cancers, confirming the effectiveness of 68Ga-PSMA-PET imaging to select patients for their lead prostate cancer therapy candidate, TLX591-Tx. The study highlights TLX591-Tx's differentiated clinical profile with good safety and…

Nayax to Report 2026 Q2 Earnings on August 10, 2026

Nayax to Report 2026 Q2 Earnings on August 10, 2026

Nayax Ltd., a global payments and commerce enablement platform listed on Nasdaq and the Tel Aviv Stock Exchange, announced it will release its Q2 2026 earnings on August 10, 2026, before U.S. markets open. The company will host two conference calls in English and Hebrew to discuss results. Nayax continues to focus on simplifying payments and enhanc…

LONG TABLE GROWTH CORP. ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING ON OR ABOUT JULY 27, 2026

LONG TABLE GROWTH CORP. ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING ON OR ABOUT JULY 27, 2026

Long Table Growth Corp., a newly public blank check company focused on business combinations across various sectors, announces that its Class A ordinary shares and warrants will begin trading separately on Nasdaq starting around July 27, 2026. Units purchased in the IPO can be separated into individual components for trading, with registration clea…

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Dyne Therapeutics, a clinical-stage biotech company focusing on genetically driven neuromuscular diseases, announced a registered underwritten public offering of $300 million in common stock, with an option for underwriters to purchase an additional $45 million. The proceeds will support the company’s clinical and preclinical programs targeting dis…

Weatherford Announces Second Quarter 2026 Results

Weatherford Announces Second Quarter 2026 Results

Weatherford International plc reported a 4% sequential decline in Q2 2026 revenues to $1.105 billion, with net income dropping 64% sequentially to $39 million, impacted by geopolitical tensions in the Middle East. The company announced acquisition of NCS Multistage to enhance its completions portfolio and launched a new plan to redomesticate from I…

Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference

Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference

Acrivon Therapeutics will present data on its proprietary AP3 platform and the clinical-stage drug ACR-2316, a novel WEE1/PKMYT1 inhibitor designed with this platform. The presentations highlight AP3’s ability to guide pathway-based drug design, demonstrating differentiated anti-tumor activity and early clinical responses including partial response…

FS Bancorp, Inc. Reports Second Quarter Net Income of $7.9 Million or $1.04 Per Diluted Share and Declares 54th Consecutive Quarterly Cash Dividend

FS Bancorp, Inc. Reports Second Quarter Net Income of $7.9 Million or $1.04 Per Diluted Share and Declares 54th Consecutive Quarterly Cash Dividend

FS Bancorp, Inc. reported net income of $7.9 million or $1.04 per diluted share for Q2 2026, marking a slight increase from the prior quarter and year-ago period. The company declared its 54th consecutive quarterly cash dividend of $0.29 per share, underscoring its commitment to shareholder returns. Total deposits decreased primarily due to a reduc…

Astera Labs: Growth Is Real, Now Trade the Momentum with a Plan

Astera Labs: Growth Is Real, Now Trade the Momentum with a Plan

Astera Labs’ connectivity chips are squarely in the path of a massive data-center build-out. Strong revenue growth, meaningful free cash flow, and recent index inclusion have pushed the stock higher, but momentum is pullback-prone. This trade idea lays out a disciplined long entry, targets, and a stop that respect valuation while leaning into conti…

Range Announces Second Quarter 2026 Results

Range Announces Second Quarter 2026 Results

Range Resources Corporation announced strong second quarter 2026 financial results, highlighting $235 million in cash flow from operating activities, record drilling and completion efficiencies, and significant share repurchases and dividends. The company reported realized natural gas prices at a $0.64 premium to NYMEX and NGL realizations at a rec…

Dentsply Sirona to Host Second Quarter Conference Call on August 6th

Dentsply Sirona to Host Second Quarter Conference Call on August 6th

Dentsply Sirona Inc., the leading manufacturer of dental products and technologies, announced plans to release its Q2 2026 financial results with a conference call and webcast on August 6, 2026. The company will provide financial earnings materials on its investor website prior to the call. The announcement offers investors a chance to gain insight…

Flyte Partners with Blade to Expand Vision Jet Distribution

Flyte Partners with Blade to Expand Vision Jet Distribution

Catheter Precision's Regional Air Mobility subsidiary, Flyte, has entered a strategic partnership with Blade Urban Air Mobility to list Flyte's Cirrus Vision Jet fleet on Blade's platform. This collaboration aims to increase customer reach, improve aircraft utilization, and accelerate brand awareness among premium aviation travelers across the Unit…